Send us Feedback

ViroPharma (VPHM)
Analysis
Data
Financials
No Sales Breakout Data.
Balance Sheet    (USD)
Annual | Quarterly
QUARTER ENDING older 30-SEP
2008		 31-DEC
2008		 31-MAR
2009		 30-JUN
2009		 30-SEP
2009		 newer
Cash & Equivalents 613M 276M 245M 267M 289M
Short Term Investments 55.6M 0 0 0 0
Accounts Receivable 23.6M 21.9M 34.6M 40.0M 38.6M
Inventories 5.14M 27.2M 30.6M 29.5M 40.4M
Pre-paid Expenses 1.10M 5.12M 4.65M 6.48M 13.1M
Deferred Tax Assets 1.01M 24.1M 16.9M 14.7M 9.68M
Other Current Assets 0 6.73M 6.73M 6.73M 6.73M
Total Current Assets 699M 361M 339M 365M 397M
Property, Plant & Equipment 14.4M 6.85M 7.21M 7.18M 6.96M
Goodwill & Intangibles 124M 670M 635M 632M 625M
Other Long-term Assets 9.44M 16.3M 12.6M 12.4M 13.8M
Total Long-Term Assets 155M 693M 655M 652M 646M
Total Assets 855M 1.05B 994M 1.02B 1.04B
Accounts Payable 4.50M 7.00M 4.29M 7.97M 12.3M
Accrued Expenses 21.5M 0 0 0 0
Short Term Debt 0 0 0 0 0
Other Current Liabilities 1.44M 820K 2.33M 959K 888K
Total Current Liabilities 27.4M 43.5M 38.1M 36.8M 39.6M
Long Term Debt 250M 250M 134M 135M 137M
Capital Lease Obligations 0 0 0 0 0
Deferred Income Tax 0 95.1M 126M 130M 128M
Other Long-term Liabilities 2.92M 4.07M 2.85M 2.78M 2.71M
Total Long-term Liabilities 253M 349M 263M 268M 268M
Minority Interest 0 0 0 0 0
Total Liabilities 280M 393M 301M 304M 307M
Preferred Stock 0 0 0 0 0
Common Par 140K 156K 156K 156K 156K
Additional Paid-In Capital 506M 595M 693M 696M 698M
Retained Earnings 67.2M 66.2M 116K 16.2M 36.2M
Treasury Stock 0 0 0 0 0
Other Equity 419K -655K -470K -446K 1.44M
Total Shareholder's Equity 574M 661M 693M 712M 736M
 
 
 
 
 
Data Sources:
Market and financial statement data provided by NASDAQ, BATS Exchange, SEC and Xignite Inc. Industry and operating metrics collected from company filings via EDGAR online. For more information on sources and calculations click here.
Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki